Pyxis Oncology, Inc. Common Stock (PYXS) is a publicly traded Healthcare sector company. As of September 8, 2026, PYXS trades at $3.89 with a market cap of $324.46M and a P/E ratio of -2.78. PYXS moved +8.98% today. Year to date, PYXS is +238.26%; over the trailing twelve months it is +103.67%. Its 52-week range spans $0.83 to $5.55. Analyst consensus is strong buy with an average price target of $7.14. Rallies surfaces PYXS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for PYXS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $3.89 |
| Market Cap | $324.46M |
| P/E Ratio | -2.78 |
| EPS | $-1.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.55 |
| 52-Week Low | $0.83 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $11.04M |
| Net Income | $-88.73M |
| Gross Margin | 0.00% |
8 analysts cover PYXS: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.14.